scholarly journals Topical 5-aminolevulinic acid photodynamic therapy for the treatment of warts: comparison of red and green light-emitting diode array

Author(s):  
Hsiung-Fei Chien ◽  
Yi-Hua Liao ◽  
Chin-Tin Chen
2004 ◽  
Vol 34 (1) ◽  
pp. 18-24 ◽  
Author(s):  
Jui-Chang Tsai ◽  
Chun-Pin Chiang ◽  
Hsin-Ming Chen ◽  
Sheng Bang Huang ◽  
Chun Wei Wang ◽  
...  

2020 ◽  
Vol 25 (06) ◽  
pp. 1 ◽  
Author(s):  
Eric M. Kercher ◽  
Kai Zhang ◽  
Matt Waguespack ◽  
Ryan T. Lang ◽  
Alejandro Olmos ◽  
...  

1999 ◽  
Vol 30 (5) ◽  
pp. 225-231 ◽  
Author(s):  
Meic H. Schmidt ◽  
Kenneth W. Reichert II ◽  
Kutlan Ozker ◽  
Glenn A. Meyer ◽  
Debra L. Donohoe ◽  
...  

2019 ◽  
Vol 93 (2) ◽  
pp. 109-115 ◽  
Author(s):  
Hideyuki Masuda ◽  
Makoto Kimura ◽  
Akiko Nishioka ◽  
Hiroshi Kato ◽  
Akimichi Morita

2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
Daniel Barolet ◽  
Annie Boucher

Photodynamic therapy (PDT) with aminolevulinic acid (ALA) to treat nodular basal cell carcinoma (BCC) has been shown to be beneficial. The success rate of ALA-PDT in the treatment of nodular BCC is dependent on optimal penetration of the photosensitizing agent and subsequent PpIX production. To enhance topical delivery of drugs intradermally, a needleless jet injection (NLJI), which employs a high-speed jet to puncture the skin without the side effects of needles, was used in one patient with recurrent BCC of the nose. Photoactivation was then performed using red light emitting diode [CW@ λ630 nm, irradiance 50 mW/cm2, total fluence 51 J/cm2] for 17 minutes. Excellent cosmesis was obtained. Aside from mild crusting present for six days, no other adverse signs were noted. Clinically, there was no recurrent lesion up two years postintervention. Additional studies in larger samples of subjects are needed to further evaluate this promising technique.


2021 ◽  
Vol 118 (2) ◽  
pp. 021102
Author(s):  
Dong-Pyo Han ◽  
Ryoto Fujiki ◽  
Ryo Takahashi ◽  
Yusuke Ueshima ◽  
Shintaro Ueda ◽  
...  

Pharmaceutics ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 1176
Author(s):  
Vanesa Pérez-Laguna ◽  
Yolanda Barrena-López ◽  
Yolanda Gilaberte ◽  
Antonio Rezusta

Candidiasis is very common and complicated to treat in some cases due to increased resistance to antifungals. Antimicrobial photodynamic therapy (aPDT) is a promising alternative treatment. It is based on the principle that light of a specific wavelength activates a photosensitizer molecule resulting in the generation of reactive oxygen species that are able to kill pathogens. The aim here is the in vitro photoinactivation of three strains of Candida spp., Candida albicans ATCC 10231, Candida parapsilosis ATCC 22019 and Candida krusei ATCC 6258, using aPDT with different sources of irradiation and the photosensitizer methylene blue (MB), alone or in combination with chlorhexidine (CHX). Irradiation was carried out at a fluence of 18 J/cm2 with a light-emitting diode (LED) lamp emitting in red (625 nm) or a white metal halide lamp (WMH) that emits at broad-spectrum white light (420–700 nm). After the photodynamic treatment, the antimicrobial effect is evaluated by counting colony forming units (CFU). MB-aPDT produces a 6 log10 reduction in the number of CFU/100 μL of Candida spp., and the combination with CHX enhances the effect of photoinactivation (effect achieved with lower concentration of MB). Both lamps have similar efficiencies, but the WMH lamp is slightly more efficient. This work opens the doors to a possible clinical application of the combination for resistant or persistent forms of Candida infections.


Sign in / Sign up

Export Citation Format

Share Document